NRX Pharmaceuticals Inc (NRXP)
3.41
+0.27
(+8.60%)
USD |
NASDAQ |
Apr 26, 13:45
NRX Pharmaceuticals Shareholders Equity (Quarterly): -11.73M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.73M |
| September 30, 2023 | -6.217M |
| June 30, 2023 | -2.808M |
| March 31, 2023 | -0.284M |
| December 31, 2022 | 7.409M |
| September 30, 2022 | 16.78M |
| Date | Value |
|---|---|
| June 30, 2022 | 25.35M |
| March 31, 2022 | 31.69M |
| December 31, 2021 | 20.81M |
| September 30, 2021 | 8.967M |
| June 30, 2021 | -17.44M |
| December 31, 2020 | -43.77M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-43.77M
Minimum
Dec 2020
31.69M
Maximum
Mar 2022
2.396M
Average
3.562M
Median
Shareholders Equity (Quarterly) Benchmarks
| Achieve Life Sciences Inc | -1.448M |
| Dare Bioscience Inc | -5.048M |
| Zevra Therapeutics Inc | 61.86M |
| Kodiak Sciences Inc | 265.78M |
| INmune Bio Inc | 38.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.315M |
| Total Liabilities (Quarterly) | 19.05M |